| |
| |
|
| Insider
Information: |
Lim Bryant David |
| Relationship: |
|
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
312,095 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$117,684 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
312,095 |
|
|
| Total
Value |
$117,684 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -162.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aceragen, Inc |
ACGN |
|
2023-01-06 |
309,695 |
2018-12-21 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
|
2023-05-24 |
2,400 |
2023-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRLD |
Prelude Therapeutics Inc |
Chief Legal Officer, Corp Sec. |
• – – |
2023-05-24 |
4 |
B |
$5.39 |
$12,936 |
D/D |
2,400 |
2,400 |
0.01 |
- |
|
| ACGN |
Aceragen, Inc |
SVP AND GENERAL COUNSEL |
• – – |
2023-01-06 |
4 |
D |
$0.71 |
$85,157 |
D/D |
(119,957) |
309,695 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
SVP AND GENERAL COUNSEL |
• – – |
2023-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
399,218 |
429,652 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
SVP AND GENERAL COUNSEL |
• – – |
2021-03-25 |
4 |
S |
$1.36 |
$10,378 |
D/D |
(7,630) |
30,434 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2021-01-12 |
4 |
S |
$4.21 |
$7,202 |
D/D |
(1,711) |
38,064 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2021-01-05 |
4 |
S |
$3.91 |
$5,722 |
D/D |
(1,465) |
39,775 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2020-01-10 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
41,240 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2020-01-07 |
4/A |
AS |
$1.78 |
$2,854 |
D/D |
(1,603) |
21,240 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2020-01-07 |
4 |
S |
$1.78 |
$2,854 |
D/D |
(1,603) |
21,240 |
0 |
% |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2019-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,100 |
22,843 |
0 |
- |
|
| ACGN |
Aceragen, Inc |
SVP and General Counsel |
• – – |
2018-12-21 |
4 |
B |
$3.05 |
$12,200 |
D/D |
4,000 |
4,743 |
2.74 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
